StonvexLoading…
StonvexStonvexStonvexCore line items from IMCR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $400.02M | $310.20M | $249.43M | $174.36M |
Operating Income | $-45.35M | $-70.46M | $-59.65M | $-51.71M |
Net Income | $-35.51M | $-51.09M | $-55.29M | $-52.54M |
EPS (Diluted) | $-0.71 | $-1.02 | $-1.13 | $-1.15 |
Total Assets | $1.07B | $1.01B | $597.00M | $526.76M |
Total Liabilities | $686.24M | $648.79M | $228.16M | $187.86M |
Cash & Equivalents | $467.71M | $455.73M | $442.63M | $402.47M |
Free Cash Flow OCF − CapEx | $-15.05M | $20.89M | $-2.48M | $-51.41M |
Shares Outstanding | 50.69M | 50.06M | 49.73M | 48.09M |